Murack M, et al
" VC firm Canaan adds $100M-plus for biotech bets and tacks on a Pfizer vet to gauge early science That initiative, in particular, helped introduce many new medicines to Pfizers pipeline, including an anti-TLA1 asset that was sold to Roivant, which flipped it to Roche for $7.1 billion
IV vitamin therapy, also known as intravenous nutrient infusion, has gained popularity in recent years as a method to boost health and wellness
Human evidence that Akkermansia raises GLP-1 exists, as described above, but the metabolic benefits in that trial were not universal, and some people will notice nothing
This creates a unique metabolic dance that the body needs time to adjust to, which is why the retatrutide dose schedule uses a gradual titration over many weeks
JAMA: The Journal Of The American Medical Association 2009, 301: 1556-1564